Inhibition of tumor necrosis factor-alpha and lnterleukin-1-beta production by beta-adrenoceptor agonists from lipopolysaccharide- stimulated human peripheral blood mononuclear cells

Pharmacology

Volumn 54, Issue 3, 1997, Pages 144-152

  Yoshimur, Tomoaki ^a   Kurita, Chikako ^a   Nagao, Tomomi ^a   Usami, Eiseki ^a   Nakao, Toshiya ^a   Watanabe, Shino ^a   Kobayashi, Joji ^a   Yamazaki, Futoshi ^a   Tanaka, Hiroyuki ^b   Inagaki, Naoki ^b   Nagai, Hiroichi ^b  

^a OGAKI MUNICIPAL HOSPITAL   (Japan)

^b GIFU PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Cyclic AMP; Interleukin 1 ; Interleukin 8; Peripheral blood mononuclear cells, human; Tumor necrosis factor ; Adrenoceptor agonist

Indexed keywords

BETA ADRENERGIC RECEPTOR STIMULATING AGENT; BUCLADESINE; CLENBUTEROL; CYCLIC AMP; CYTOKINE; FENOTEROL; INTERLEUKIN 1BETA; INTERLEUKIN 8; LIPOPOLYSACCHARIDE; PROCATEROL; PROPRANOLOL; TERBUTALINE; THEOPHYLLINE; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL STIMULATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; INFLAMMATION; MONONUCLEAR CELL; NORMAL HUMAN; PRIORITY JOURNAL;

ADRENERGIC BETA-AGONISTS; ADRENERGIC BETA-ANTAGONISTS; CELL SEPARATION; CELLS, CULTURED; CLENBUTEROL; CYCLIC AMP; DRUG INTERACTIONS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FENOTEROL; HUMANS; INTERLEUKIN-1; INTERLEUKIN-8; LEUKOCYTES, MONONUCLEAR; LIPOPOLYSACCHARIDES; PROCATEROL; PROPRANOLOL; TERBUTALINE; THEOPHYLLINE; TUMOR NECROSIS FACTOR-ALPHA; VASODILATOR AGENTS;

EID: 0030949830     PISSN: 00317012     EISSN: 14230313     Source Type: Journal    
DOI: 10.1159/000139481     Document Type: Article

References (31)

1. Giembycz MA. Raeburn D: Putative substrates for cyclic nucleotide-dependent protein kinases and the control of airway smooth muscle tone. J Auton Pharmacol 1991;II: 365-398.
2. Plaut M. Marone G, Thomas LL, Lichtenstein LM: Cyclic nucleotides in immune responses and allergy. Adv Cyclic Nucleotide Res 1980; 12: 161-172.
3. Kuehl FA. Zanetti ME. Soderman DD, Miller DK, Ham EA: Cyclic AMP-dcpcndcnt regulation of lipid mediators in white cells. A unifying concept for explaining the efficacy of theophylline in asthma. Am Rev Respir Dis 1987:136:210-213.
4. Knudsen TE, Larsen CS. Johnsen HE: A study of cyclic nucleotides as second messengers after interlcukin-2 stimulation of human T lymphocytes. Scand J Immunol 1987,25: 527-531.
5. Butchers PR. Skidmore IF, Vardey CJ. Wheeldon A: Characterization of the receptor mediating antiana-phylactic effects of beta-adrcnoccp-tor agonists in human lung tissues in vitro. Br.l Pharmacol 1980;71:663-667.
6. Church MK. Hiroi J: Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbu-tamol. Br J Pharmacol 1987:90: 421-429.
7. Déni G, Gicmbycz MA. Rabe KF, Evans PM. Barnes PJ: Suppression of respiratory burst in human eosinophils by phosphodiesterase inhibitors: Interaction with the p-reccptor agonist albuterol. J Pharmacol Exp Ther 1994;271:1167-1174.
8. Munoz NM. Vita AJ, Neclv SP, McAllister K, Spaethc SM. White SM. Leff AR: Beta adrenergic modulation of formyl-methioninc-lcu-cinc-phenylalanine stimulates secretion of eosinophil peroxidase and leukotriene Cj. J Pharmacol Exp Ther 1994:268:139-143.
9. Kita H, Abu-Ghazaleh RI. Gleich GJ, Abraham RT: Regulation of Ig-induced eosinophil degranulation by adenosine-3', 5'-cyclic monophosphate. J Immunol 1991:146: 2712-2718.
10. Baumann H, Gauldie J: The acute phase response. Immunol Today 1994;15:74-80.
11. Old U: Tumor necrosis factor; in Bonavida B, Granger G (eds); Tumor Necrosis Factor: Structure. Mechanism of Action, Role in Disease and Therapy. Basel. Karger. 1990. pp 1-30.
12. Dinarello CA: Interleukin-1 and its biologically related cytokines. Adv Immunol 1989;44:153-205.
13. Yoshimura T, Matsushima K, Tanaka S. Robinson EA, Appella E, Op-penheim JJ. Leonard EJ: Purification of a human monocyte-derived neutrophil chemotactic factor that has peptide sequence similarity to other host defense cytokines. Proc Natl Acad Sci USA 1987:84:9233-9237.
14. Spatafora M. Chiappara G. Meren-dino AM, D’Amico D, Bellia V, Bonsignore G: Theophylline suppresses the release of tumor necrosis factor-a by blood monocytes and alveolar macrophages. Eur Respir J 1994:7:223-228.
15. Semmler J, Gebert U. Eiscnhut T, Moeller J. Schonharting MM, Allcra A, Endres S: Xanthine derivatives: Comparison between suppression of tumor necrosis factor-a production and inhibition of cAMP phosphodiesterase activity. Immunology 1993;78:520-525.
16. Verghese MW, Mcconnell RT. Strickland AB. Gooding RC. Stimp-son SA. Yamatl DP, Taylor JD. Fur-don PJ: Differential regulation of human monocyte-derived TNF-a and IL-lß by type IV cAMP-phos-phodiesterase (cAMP-PDE) inhibitors. J Pharmacol Exp Ther 1994; 272:1313-1320.
17. Yoshimura T. Usami E, Kurita C. Watanabe S. Nakao T, Kobayashi J. Yamazaki F. Nagai H: Effect of theophylline on the production of interleukin-Iß, tumor necrosis factor-u. and interleukin-8 by human peripheral blood mononuclear cells. Biol Pharm Bull 1995;18:1405-1408.
18. Scales WE, Chcnsuc SW, Otlemess I. Kunkel SL: Regulation of monokine gene expression: Prostaglandin Ei suppresses tumor necrosis factor but not interleukin-1α or β-mRNA and cell-associated bioactivity. J Leukoc Biol 1989:45:416-421.
19. Endres S. Fülle HJ. Sinha B. Stoll D, Dinarello CA. Gcrzer R. Weber PC: Cyclic nucleotides differentially regulate the synthesis of tumor necrosis factor-a and interleukin-Iß by human mononuclear cells. Immunology 1991:72:56-60.
20. Viherluoto J, Palkama T. Silven-noinen O. Htirme M: Cyclic adenosine monophosphate decreases secretion. but not the cell-associated levels, of interleukin-lß in lipopoly-saccharide-activaled human monocytes. Scand. J Immunol 1991:34: 121-125.
21. Kariman K: β-Adrenergic receptor binding in lymphocytes from patients with asthma. Lung 1980; 158: 41-51.
22. Yukawa T. Ukena D. Krocgel C. Chancz P. Dent G. Chung KF, Barnes PJ: Beta 2-adrenergic receptors on eosinophils: binding and functional studies. Am Rev Respir Dis 1990;141:1446-1452.
23. Liggett SB: Identification and characterization of a homogeneous population of p2-adrenergic receptors on human alveolar macrophages. Am Rev Respir Dis 1989;139:552-555.
24. Hjemdahl P. Larsson K, Johansson MC. Zetterlund A. Eklund A: β-Adrcnoceptors in human alveolar macrophages isolated by elutriation. Br J Clin Pharmacol 1990:30:673-682.
25. van Oosterhout AJM, Stant WB, Vanderschueren RGJRA. Nijkamp FP: Effects of cytokines on α-adre-noceptor function of human peripheral blood mononuclear cells and guinea pig trachea. J Allergy Clin Immunol 1992;90:340-348.
26. Wills-Karp M. Uchida Y, Lee JY. Jinot J. Hirata A. Hirata F: Organ culture with proinfiammatory cytokines reproduces impairment of the α-adrcnoceptor-mediated relaxation in tracheas of a guinea pig antigen model. Am J Respir Cell Mol Biol 1993;8:153-159.
27. Pauwels RA: New aspects of the therapeutic potential of theophylline in asthma. J Allergy Clin Immunol 1989:83:548-553.
28. Crcscioli S, Spinazzi A. Plebani M. Pozzani M, Mapp CE. Boschetto P. Fabbri 1.M: Theophylline inhibits early and late asthmatic reaction induced by allergens in asthmatic subjects. Ann Allergy 1991:66:245-251.
29. Sullivan P. Bckir S. Jaffar Z. Pagc C, Jeffery P. Costello J: Anti-inflammatory effects of low-dose oral theophylline in atopic asthma. Lancet 1994;343:1006-1008.
30. Ramage L, Cree IA, Dhillon DP: Comparison of salmcterol with placebo in mild asthma: Effect on peripheral blood phagocyte function and cytokine levels. Int Arch Allergy Immunol 1994;105:181-184.
31. Gardiner PV, Ward C, Booth H. Allison A, Hendrick DJ, Walters EH: Effect of eight weeks of treatment with salmcterol on bronchoalveolar lavage inflammatory indices in asthmatics. Am J Respir Crit Care Med 1994:150:1006-1011.